CANCER BUZZ speaks with Melissa Kah Poh Loh, MBBCh, BAO, assistant professor of Geriatric Hematology and Oncology about strategies to optimize critical conversations with patients with acute myeloid leukemia.
Find the CANCER BUZZ podcast on Apple Podcasts, Spotify, or wherever you get your podcasts!
Personalizing care goals to account for a patient’s values, preferences, or circumstances can make a significant difference in shared decision-making and treatment planning. In this episode, CANCER BUZZ speaks with Melissa Kah Poh Loh, MBBCh, BAO, assistant professor of Geriatric Hematology and Oncology at the University of Rochester Medical Center’s Wilmot Cancer Institute about strategies to optimize critical conversations with patients with acute myeloid leukemia.
“For older adults with acute myeloid leukemia, the treatment landscape has changed in the last few years…and their [patients’] preferences and goals really make a difference in what we ultimately choose together with patients and family members…incorporating this as part of the conversation is very important.” – Melissa Kah Poh Loh, MBBCh, BAO
Melissa Kah Poh Loh, MBBCh, BAO
Assistant Professor of Geriatric Hematology and Oncology
University of Rochester Medical Center, Wilmot Cancer Institute
Rochester, NY
This is the second episode of a four-part series developed in connection with the ACCC education programAchieving and Maintaining Better Outcomes for Patients with Acute Myeloid Leukemia. This episode was made possible with support by Bristol Myers-Squibb.
The views and opinions expressed herein are those of the author(s)/faculty member(s) and do not reflect the official policy or position of their employer(s) or the Association of Cancer Care Centers.
July 8, 2026
June 30, 2026
At the 2026 ASCO Annual Meeting, the Louisiana Oncology Society received the ASCO Jeffrey C Ward Affiliate Advocacy Award for advancing critical advocacy priorities that have translated into meaningful legislative victories. The Iowa Oncology Society and Washington State Medical Oncology Society were also recognized for their advocacy efforts in 2025 at the meeting, receiving second place awards.
